Alyeska Investment Group, L.P.

Position in LLY — ELI LILLY & Co

CIK 1453072 CHICAGO, IL

Position in LLY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$688,472

+$127,489 QoQ

Shares Held

574

+10.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#3,462

of 4,605 holders

Holding Since

Sep 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Alyeska Investment Group, L.P. holds $909,020,667 across 5 Drug Manufacturers - General names. LLY ranks #5 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	2,480,590	$318,755,815
2	JNJ	Johnson & Johnson	1,173,482	$298,029,223
3	BIIB	Biogen Inc.	932,374	$201,448,726
4	SNY	Sanofi	2,112,012	$90,098,431
5	LLY	ELI LILLY & Co This page	574	$688,472

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$688,472	574	+10.0%	Shares	Sole	2026-08-14
2025-12-31	$560,983	522	-82.9%	Shares	Sole	2026-02-13
2025-03-31	$2,523,155	3,055	-96.3%	Shares	Sole	2025-05-15
2024-06-30	$74,311,779	82,078	-48.8%	Shares	Sole	2024-08-14
2024-03-31	$124,741,218	160,344	-16.1%	Shares	Sole	2024-05-15
2023-12-31	$111,385,519	191,082	+21.8%	Shares	Sole	2024-02-14
2023-09-30	$84,242,932	156,839	-40.1%	Shares	Sole	2023-11-14
2022-09-30	$84,628,455	261,724	+8405.8%	Shares	Sole	2022-11-14
2021-12-31	$849,928	3,077	-98.6%	Shares	Sole	2022-02-14
2021-09-30	$50,437,983	218,299	+38.2%	Shares	Sole	2021-11-15
2021-06-30	$36,249,700	157,937	-0.1%	Shares	Sole	2021-08-16
2021-03-31	$29,544,462	158,144	-32.5%	Shares	Sole	2021-05-17
2020-12-31	$39,530,002	234,127	+10.3%	Shares	Sole	2021-02-16
2020-09-30	$31,413,692	212,226	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.